SkinTE is currently available for investigational use only. Submission of a biologics license application (BLA) to the U.S. Food and Drug Administration is expected in 2026, after which additional ...
Quality playbook systems preparing for outpatient procedure expansion focus on protocols, outcomes tracking, and staff readiness amid CMS rule changes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback